recurrent malignant testicular germ cell tumor
Showing 1 - 7 of 7
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
Adult CNS Germ Cell Tumor, Adult Teratoma, Malignant Extragonadal Germ Cell Tumor Trial in Indianapolis, Philadelphia, Seattle
Terminated
- Adult Central Nervous System Germ Cell Tumor
- +9 more
-
Indianapolis, Indiana
- +2 more
Jun 11, 2015
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +61 more
- ipilimumab
- therapeutic allogeneic lymphocytes
-
La Jolla, California
- +4 more
Mar 26, 2013
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas Trial in Philadelphia
Completed
- Adenocarcinoma of the Colon
- +41 more
- recombinant fowlpox-CEA(6D)/TRICOM vaccine
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 24, 2013
Ovarian Dysgerminoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor Trial in Chicago (drug,
Terminated
- Ovarian Dysgerminoma
- +7 more
- imatinib mesylate
- +2 more
-
Chicago, IllinoisCancer and Leukemia Group B
Jan 15, 2013
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Withdrawn
- Accelerated Phase Chronic Myelogenous Leukemia
- +102 more
- management of therapy complications
- musculoskeletal complications management/prevention
- (no location specified)
Jul 5, 2012